Brief: Adocia's M1Pram Leads To Weight Loss For Obese People With Type 1 Diabetes

Adocia SA

06/10/2022 06:34

Oct 6 (Reuters) - ADOCIA SA  ADOC.PA :
    * ADOCIA ANNOUNCES EXCEPTIONAL WEIGHT LOSS FOR OBESE PEOPLE
WITH
TYPE 1 DIABETES USING M1PRAM IN A POST-HOC ANALYSIS
    * M1PRAM COFORMULATION IS PATENTED BY ADOCIA UNTIL 2038
    * GLYCEMIC CONTROL EFFICACY COMPARABLE TO THAT OBTAINED WITH
COMMERCIAL REFERENCE INSULIN HUMALOG
    * M1PRAM REDUCED DAILY DOSE OF PRANDIAL INSULIN BY 21% IN
GENERAL
POPULATION OF STUDY

Source text for Eikon:  ID:nBwZX0xba 
Further company coverage:  ADOC.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))